Vitamin E protects patients from cisplatin-induced neuropathy in a randomized trial.
Reference: Pace A, Giannarelli D, Galie E, et al. Vitamin E neuroprotection for cisplatin neuropathy. Neurology 2010;74:762-6.
Design: Randomized double blind intervention trial
Participants: Of 108 patients initially randomized in the trial, 41 were treated with cisplatin exceeding 300 mg/[m.sup.2]. Of these 41 subjects, 17 had been given vitamin E and 24 had been given placebo.
Study Medication and Dosage: 596 IU d-alpha tocopherol or placebo daily, begun 1 to 8 days before the start of cisplatin therapy and continued for 3 months following discontinuation of cisplatin therapy
Outcome Measures: Development of peripheral neuropathy as a result of cisplatin therapy and measurement of the severity of the neurological damage through the use of Total Neuropathy Score (TNS)
Key Findings: Neurotoxicity occurred in 6% in the vitamin E group versus 42% in the placebo group (p < 0.01). The severity of neurological damage was also far lower in the vitamin E group (1.4 TNS versus 4.1; p < 0.01).
Practice Implications: Cisplatin use is limited by severe neurotoxicity. When the cumulative dose exceeds 300 mg/[m.sup.2], in some reports most patients suffer significant neurological damage. Cisplatin is known to increase oxidative stress, vitamin E is an antioxidant, and current evidence suggests that the antioxidant actions of vitamin E do not interfere with the therapeutic effect of chemotherapy (Int J Cancer 2003;104:243-50). Neuropathy has been reported to occur as part of the presentation of vitamin E deficiency. As a result, researchers are interested in exploring the ability of vitamin E to protect against cisplatin-induced neuropathies.
In 2007, a Cochrane review concluded that previous evidence linking the use of vitamin E to protection against neuropathy in patients given cisplatin was encouraging but needed additional support from randomized clinical trials (Cochrane Database Syt Rev 2007;1:CD005228). The findings of the new trial take us a significant step in that direction. Until more is known, all patients given cisplatin should concomitantly take vitamin E supplements beginning several days before the start of the chemotherapy.
by: Steve Austin, N.D.
Submitted by: Emerson Ecologics
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Abstracts of Interest|
|Date:||Sep 1, 2010|
|Previous Article:||St. John's Wort for menopausal symptoms.|
|Next Article:||Oral magnesium again reported to help asthma sufferers in a randomized trial.|